Furthermore, this one was started with venture capital. So selling the company is a normal part of the process when VC is involved.
But if it happens it's probably going to be very expensive.
"The innovations developed by Dr. Khine have become the core of what is now Shrink Nanotechnologies. The Company has 11 exclusive patent pending technologies and is developing products and licensing partnerships in three main vertical markets including Solar Energy, Medical and Diagnostic Sensors and Research Tools to fuel innovation in some of the most important medical fields."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.